Holdings of Medicxi Ventures Management (Jersey) Ltd
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 3 in 2 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Centessa Pharmaceuticals PLC | 19,963,157 | 792.9M $ | |
| 2 | Phathom Pharmaceuticals Inc | 7,464,572 | 82.9M $ | |
| 3 | Aura Biosciences Inc | 3,039,892 | 20.3M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United Kingdom 88.5 %
- United States 11.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United Kingdom | 1 | 792.9M $ | 88.48 % |
| 2 | United States | 2 | 103.3M $ | 11.52 % |
Cite this page
Titelia. "Holdings of Medicxi Ventures Management (Jersey) Ltd". https://titelia.com/en/funds/US13F1715579